Jesus Jeniffer, Aguiar Catarina, Meira Dália, Rodriguez-Una Ignacio, Beirão João M
Unidade Local de Saúde Entre o Douro e Vouga, 4520-211 Santa Maria da Feira, Portugal.
Unidade Local de Saúde Gaia e Espinho, 4405-678 Vila Nova de Gaia, Portugal.
J Clin Med. 2025 May 9;14(10):3317. doi: 10.3390/jcm14103317.
: In 2010, approximately 60.5 million people were affected by glaucoma, making it the leading cause of permanent vision impairment globally. With the rise of telehealth tools and technological advancements in glaucoma care, this review aims to provide an up-to-date analysis regarding remote monitoring systems in glaucoma management. : A systematic literature search (in compliance with PRISMA guidelines) was conducted across six databases (CINAHL, MEDLINE, PsycINFO, Web of Science, Scopus, and Cochrane Library) and one grey literature source (Google Scholar), covering the period from 2000 to 2024. Relevant studies meeting predefined inclusion criteria were identified and analyzed. : The search identified 21 eligible studies focusing on various glaucoma telemonitoring tools. Several studies demonstrated the potential for continuous remote intraocular pressure (IOP) monitoring and highlighted the effectiveness of home-based visual field-testing technologies (e.g., Melbourne Rapid Fields, Eyecatcher, and VF-Home), which showed results closely matching in-clinic tests. All 21 studies underwent risk of bias assessment with appropriate tools based on study design, and none showed a high overall risk of bias, indicating robust methodology. : Glaucoma telemonitoring tools are feasible and cost-effective, helping to reduce patient travel and waiting times and improving patient satisfaction. However, periodic in-person examinations remain necessary to optimally monitor disease progression and adjust treatments. Future directions should focus on interdisciplinary collaboration and the development of advanced algorithms (including artificial intelligence) to further enhance patient outcomes in teleglaucoma care.
2010年,约6050万人受青光眼影响,这使其成为全球永久性视力损害的主要原因。随着远程医疗工具的兴起以及青光眼护理技术的进步,本综述旨在提供关于青光眼管理中远程监测系统的最新分析。
按照PRISMA指南进行了系统的文献检索,检索了六个数据库(CINAHL、MEDLINE、PsycINFO、Web of Science、Scopus和Cochrane图书馆)以及一个灰色文献来源(谷歌学术),涵盖2000年至2024年期间。确定并分析了符合预定义纳入标准的相关研究。
检索确定了21项关注各种青光眼远程监测工具的合格研究。几项研究证明了连续远程眼压(IOP)监测的潜力,并强调了家庭视野测试技术(如墨尔本快速视野、EyeCatcher和VF-Home)的有效性,这些技术显示的结果与临床测试结果非常匹配。所有21项研究都根据研究设计使用适当工具进行了偏倚风险评估,没有一项显示出高总体偏倚风险,表明方法学可靠。
青光眼远程监测工具是可行且具有成本效益的,有助于减少患者就诊和等待时间,并提高患者满意度。然而,定期的面对面检查对于最佳监测疾病进展和调整治疗仍然是必要的。未来的方向应侧重于跨学科合作以及先进算法(包括人工智能)的开发,以进一步改善青光眼远程护理中的患者预后。